Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4 Study: Induction Therapy for Thoracic Esophageal Cancer Invading Aorta or Trachea
jRCTs051180164Phase 2Completed
- Start
- Mar 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of docetaxel, cisplatin and fluorouracil in esophageal cancer (2 arms). Primary endpoint: 2-year survival rate. Started Mar 2014; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCTs051180164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180164.